28 Fingolimod 0.25 mg demonstrated a numerical reduction in the aggregate annualized relapse rate (14.6%) compared to glatiramer acetate, findings that failed to reach statistical significance.
← all excerpts
Clinical and radiological implications of subpotent generic fingolimod in multiple sclerosis: a case series.
1
—
—